| [1] |
WHO Classification of Tumours Editorial Board. WHO classification of tumours: soft tissue and bone tumours[M]. 5th ed. Lyon: IARC Press, 2020.
|
| [2] |
Kalmykova AV, Baranovska⁃Andrigo V, Michal M. Update on cutaneous mesenchymal tumors in the 5th edition of WHO classification of skin tumors with an emphasis on new fusion⁃associated neoplasms[J]. Virchows Arch, 2024,485(5):777⁃792. DOI: 10.1007/s00428⁃024⁃03925⁃2.
|
| [3] |
Carter JM, Weiss SW, Linos K, et al. Superficial CD34⁃positive fibroblastic tumor: report of 18 cases of a distinctive low⁃grade mesenchymal neoplasm of intermediate (borderline) malignancy[J]. Mod Pathol, 2014,27(2):294⁃302. DOI: 10.1038/modpathol. 2013.139.
|
| [4] |
Perret R, Michal M, Carr RA, et al. Superficial CD34⁃positive fibroblastic tumor and PRDM10⁃rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases[J]. Histopathology, 2021,79(5):810⁃825. DOI: 10.1111/his.14429.
|
| [5] |
Klubíčková N, Dermawan JK, Mosaieby E, et al. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations[J]. J Pathol, 2024,263(1):61⁃73. DOI: 10.1002/path.6260.
|
| [6] |
Kao Y, Suurmeijer AJH, Argani P, et al. Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis⁃like neural tumor pattern[J]. Genes Chromosomes Cancer, 2020,59(10):575⁃583. DOI: 10.1002/gcc.22877.
|
| [7] |
Hsiao SJ, Zehir A, Sireci AN, et al. Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy[J]. J Mol Diagn, 2019,21(4):553⁃571. DOI: 10.1016/j.jmoldx.2019.03.008.
|
| [8] |
宋昊, 卢舒怡, 邵雪宝, 等. CRTC1::TRIM11融合皮肤肿瘤5例报道[J]. 中华皮肤科杂志, 2026,59(2):127⁃132. DOI: 10.35541/cjd.20250558.
|
| [9] |
Hanna J, Ko JS, Billings SD, et al. Cutaneous melanocytic tumor with CRTC1::TRIM11 translocation: an emerging entity analyzed in a series of 41 cases[J]. Am J Surg Pathol, 2022,46(11):1457⁃1466. DOI: 10.1097/PAS.0000000000001952.
|
| [10] |
Yang L, Yin Z, Wei J, et al. Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than indolent?[J]. Histopathology, 2023,82(2):368⁃371. DOI: 10.1111/his.14812.
|
| [11] |
de la Fouchardiere A, Pissaloux D, Tirode F, et al. Clear cell tumor with melanocytic differentiation and ACTIN⁃MITF translocation: report of 7 cases of a novel entity[J]. Am J Surg Pathol, 2021,45(7):962⁃968. DOI: 10.1097/PAS.0000000000 001630.
|
| [12] |
de la Fouchardiere A, Pissaloux D, Tirode F, et al. Clear cell tumor with melanocytic differentiation and MITF⁃CREM translocation: a novel entity similar to clear cell sarcoma[J]. Virchows Arch, 2021,479(4):841⁃846. DOI: 10.1007/s00428⁃021⁃03027⁃3.
|
| [13] |
Alexandrescu S, Imamovic⁃Tuco A, Janeway K, et al. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation[J]. J Cutan Pathol, 2023,50(7):619⁃622. DOI: 10.1111/cup.14427.
|
| [14] |
Perret RE, Jullie M, Vergier B, et al. A subset of so⁃called dermal non⁃neural granular cell tumours are underlined by ALK fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma[J]. Histopathology, 2018,73(3):532⁃534. DOI: 10.1111/his.13645.
|
| [15] |
DeSimone MS, Odintsov I, Tsai HK, et al. Epithelioid fibrous histiocytoma is on a continuum with superficial ALK ⁃rearranged myxoid spindle cell neoplasm: a clinicopathologic series of 35 cases including alternate RET and NTRK3 fusions[J]. Am J Surg Pathol, 2024,48(12):1568⁃1579. DOI: 10.1097/PAS.0000 000000002315.
|
| [16] |
Dadone⁃Montaudié B, Alberti L, Duc A, et al. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions[J]. Mod Pathol, 2018,31(11):1683⁃1693. DOI: 10.1038/s41379⁃018⁃0089⁃4.
|
| [17] |
Bouvier C, Le Loarer F, Macagno N, et al. Recurrent novel THBS1⁃ADGRF5 gene fusion in a new tumor subtype "Acral FibroChondroMyxoid Tumors"[J]. Mod Pathol, 2020,33(7):1360⁃1368. DOI: 10.1038/s41379⁃020⁃0493⁃4.
|
| [18] |
Saoud C, Agaimy A, Dermawan JK, et al. A comprehensive clinicopathologic and molecular reappraisal of GLI1⁃altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1⁃ amplified versus GLI1⁃rearranged tumors[J]. Am J Surg Pathol, 2024,48(10):1302⁃1317. DOI: 10.1097/PAS. 0000000000002272.
|